About
What is ADNP
Our Story
Our Mission & Team
Inclusivity Statement
RESEARCH
Research Update 2.2024
ADNP Patient Registry & Natural History
Research Projects 2023
Research Strategy
Ketamine Trial
Ketamine Trial Publication
Ketamine Update
FAMILIES
NEWS
Giving Tuesday
NET Collaboration Study
Ketamine Trial Phase 2 Announcement
>
Glimpse of Hope RDD 2020
Mount Sinai Launches First Drug Trial for ADNP Syndrome
Seaver Midtown Partnership
Biomarker Discovered
NEWS - p.Tyr719* Case Study
NEWS HIGHLIGHTS- ADNP Syndrome Family Conference
DONATE/SUPPORT
Warrior Fun Run
>
Past Fun Run Pictures
Sponsorship Opportunity
Third Party Fundraising
ADNP STORE
contact us
ADNP STORE
UC DAVIS / MIND INSTITUTE LAUNCHES $4-MILLION DOLLAR GENE THERAPY PROGRAM FOR ADNP
PARENTS FIND GLIMPSE OF HOPE FOR TREATMENT OF THEIR CHILDREN'S RARE GENETIC DISORDER
KETAMINE ANNOUNCEMENT
RARE DISEASE ORGANIZATIONS COLLABORATING TO ACCELERATE SCIENTIFIC DISCOVERY EVALUATION TOOL FOR AUTISM AND RELATED DISORDERS.
1ST ADNP SYNDROME FAMILY CONFERENCE AND SCIENTIFIC SYMPOSIUM HIGHLIGHTS
BIOMARKER ANNOUNCEMENT
NEWS RELEASE AUTISM LINKED BIOMARKER
NEWS RELEASE - P.TYR719* CASE STUDY
About
What is ADNP
Our Story
Our Mission & Team
Inclusivity Statement
RESEARCH
Research Update 2.2024
ADNP Patient Registry & Natural History
Research Projects 2023
Research Strategy
Ketamine Trial
Ketamine Trial Publication
Ketamine Update
FAMILIES
NEWS
Giving Tuesday
NET Collaboration Study
Ketamine Trial Phase 2 Announcement
>
Glimpse of Hope RDD 2020
Mount Sinai Launches First Drug Trial for ADNP Syndrome
Seaver Midtown Partnership
Biomarker Discovered
NEWS - p.Tyr719* Case Study
NEWS HIGHLIGHTS- ADNP Syndrome Family Conference
DONATE/SUPPORT
Warrior Fun Run
>
Past Fun Run Pictures
Sponsorship Opportunity
Third Party Fundraising
ADNP STORE
contact us
ADNP STORE